Teodora Andonova
Stockholm, AB, Sweden
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Inhibition of Rho-Associated Kinase Suppresses Medulloblastoma Growth.
Journal: Cancers
Published: November 11, 2019
Targeting Fibroblast Growth Factor Receptor (FGFR) and Phosphoinositide 3-kinase (PI3K) Signaling Pathways in Medulloblastoma Cell Lines.
Journal: Anticancer research
Published: October 31, 2019
Analyses of FGFR3 and PIK3CA mutations in neuroblastomas and the effects of the corresponding inhibitors on neuroblastoma cell lines.
Journal: International journal of oncology
Published: June 15, 2019
In vitro antitumor effects of FGFR and PI3K inhibitors on human papillomavirus positive and negative tonsillar and base of tongue cancer cell lines.
Journal: Oncology letters
Published: May 16, 2019
ERV1/ChemR23 Signaling Protects Against Atherosclerosis by Modifying Oxidized Low-Density Lipoprotein Uptake and Phagocytosis in Macrophages.
Journal: Circulation
Published: May 10, 2018
Resolution of Inflammation Through the Lipoxin and ALX/FPR2 Receptor Pathway Protects Against Abdominal Aortic Aneurysms.
Journal: JACC. Basic to translational science
Published: April 02, 2018
Rho-associated kinase is a therapeutic target in neuroblastoma.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: July 26, 2017
Showing 1-8 of 8
Last Updated: 09/26/2026